Mostrando 4 resultados de: 4
Filtros aplicados
Publisher
Revista Latinoamericana de Hipertension(2)
Archivos Venezolanos de Farmacologia y Terapeutica(1)
Cardiology Research and Practice(1)
Área temáticas
Enfermedades(4)
Farmacología y terapéutica(3)
Medicina y salud(2)
Economía(1)
Medicina forense; incidencia de enfermedades(1)
Área de conocimiento
Enfermedad cardiovascular(1)
Infección(1)
Inflamación(1)
Medicamento(1)
Nutrición(1)
C-reactive protein: Clinical and epidemiological perspectives
ReviewAbstract: An important etiopathogenic component of cardiovascular disease is atherosclerosis, with inflammatioPalabras claves:Autores:Añez-Ramos R., Apruzzese V., Chávez-Castillo M., Martínez M.S., Rojas-Quintero J., Salazar-Vílchez J., Silva C., Toledo A.C., Torres Y., Valmore BermúdezFuentes:scopusFront-line medicines used in the treatment of tuberculosis
ArticleAbstract: Tuberculosis has emerged as an enormous global public health epidemic. Worldwide, it is the second lPalabras claves:Estreptomicin, Ethambutol, isoniazid, M. Tuberculosis, Pyrazinamide, rifampinAutores:Arráiz N., Bermúdez F.A., Leal E.M., Rodriguez M., Silva C., Valdelamar L., Valmore BermúdezFuentes:scopusLipid profile reference intervals in individuals from Maracaibo, Venezuela: An insight from the Maracaibo City Metabolic Syndrome prevalence study
ArticleAbstract: Objectives: Cardiovascular diseases are the main cause of death in adults worldwide. Dyslipidemias aPalabras claves:Cardiovascular disease, dyslipidemia, lipid profile, Reference intervalsAutores:Aguirre M.A., Añez-Ramos R., Angulo V., Arráiz N., Bello L.M., Carem Prieto, Fortul Y., González M.C., Linares S., Marcano R.P., Naguib A., Pacheco E., Ponce C.C., Rojas-Quintero J., Salazar-Vílchez J., Silva C., Toledo A.C., Torres Y., Valmore Bermúdez, Villalobos M.Fuentes:googlescopusSerum lipoprotein (a) in patients post myocardial infarction
ArticleAbstract: Lipoprotein (a) [Lp (a)] is considered an independent risk factor for cardiovascular disease. In ourPalabras claves:Abdominal circumference, body mass index, dyslipidemia, Lipoprotein (a), myocardial infarctionAutores:Amell A., Añez-Ramos R., Arráiz N., Cano-Ponce C., Carem Prieto, Carrillo M., Cruz S., González M.C., Joselyn Zula, Montiel M., Salazar-Vílchez J., Silva C., Toledo A.C., Torres Y., Valmore Bermúdez, Vergara P.M.Fuentes:googlescopus